TECNICAS DE CITOMETRIA:
1.- RILEY RS, MAHIN EJ. Flow cytometry. Clinical applications. Seattle, Washington. ASCP Workshop #9072. 1989.
2.- KOSS LG, CZERNIAK B, HERZ F, WERSTO R. Flow cytometric measurements of DNA and other cell components in human tumors: A critical appraisal. Hum. Pathol. 1989; 20:528-548.
3.- WHEELEESS LL Jr. Flow instrumentation and data analysis. In Diagnostic Flow Cytometry. Coon JS, Weinstein RS. Williams & Wilkins. Baltimore 1991. pp 17-34.
4.- VINDELOV LL. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method por rapid isolation and staining of nuclei. Virchows Arch. B Cell Path. 1977; 24:227-242.
5.- HEDLEY DW, FRIEDLANDER ML, TAYLO IW et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histocem. Cytochem. 1983; 31:1333-1335.
6.- COON JS, LANDAY AL, WEINSTEIN RS. Flow cytometric analysis of paraffin-embedded tumors: Implications for diagnostic Pathology. Hum. Pathol. 1986; 17: 435-437.
7.- FRIERSON HF. Flow cytometric analysis of ploidy in solid neoplasms: Comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. Hum. Pathol. 1988; 19:290-294.
8.- McCARTHY RC, FETTERHORF TJ. Issues for quality assuranse in clinical flow cytometry. Arch. Pathol. Lab. Med. 1989; 113:658-666
TUMORES DE LA GLANDULA MAMARIA
1.- Auer GU; Caspersson T; Gustafsson S: Relationship between nuclear DNA distribution and oestrogen receptor in human mammary carcinomas. Anal Quant Cytol. 1980, 2: 280-84.
2.- ChristovK; Milev A; Todorov V: DNA aneuploudy and cell proliferation in breast tumors. Cancer. 1989. 64: 673-679
3.- Fisher B; Gunduz N; Constantino J; Fisher E; Redmon C; Mamounos E; SideritsR: DNA flow cytometric analysis of primary operable breast cancer. Cancer 1991. 68: 1465-1475
4.- Susnik B; Poulin N; Phillips D; LeRiche J; Palcic B. Comparison of DNA measurement performed by flow and image cytometry of embedded breast tissue sections. Anal Quant Cytol Histol. 1995 Jun. 17(3). 163-71.
5.- Lewis W: Prognostic significance of flow cytometric DNA analysis in node negative breast cancer patients. Cancer. 1990. 65: 2315-2320
6.- Keyhani-Rofagha S; O'toole R; Farrar W; Sicklesantanello B; De Cenzo J; Young D: Is DNA ploidy an independent prognostic indicator in infiltrative node negative breast adenocarcinoma. Cancer. 1990. 1577-1582.
7.- Dobrynin IaV; Nikolaeva TG; Letiagin VP; Alferov VS; Prorokov VV: DNA ploidy of tumor cells in prognostication of the course of malignant neoformations: (English abstract) Vestn Ross Akad Med Nauk. 1995. (4). 45-50.
8.- Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer. 1995 Apr 15. 75(8). 2123-31.
9.- Hakama M; Holli K; Isola J; Kallioniemi OP; Karkkainen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J; et al: Aggressiveness of screen-detected breast cancers Lancet. 1995 Jan 28. 345(8944). 221-4.
10.- Zandona C; Budel V; Larsimont D; Petein M; Gasperin P; Pasteels JL; Kiss R: Digital cell image analysis of Feulgen-stained nuclei from human papillary, medullary, colloid, lobular and comedocarcinomas of the breast. Anticancer Res. 1994 Sep-Oct. 14(5B). 2173-82.
11.- Cook DL; Weaver DL: Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast. Am J Clin Pathol. 1995 Jul. 104(1). 17-22.
12.- Ameloöv C; Emdin S; Roos G; Angströnm T et al. Prognostic factors in locally advanced breast cancer (T3, T4) with special reference to tumor cell DNA content. Acta Oncológica. 1987. 27. 221-226.
13.- Veilleux C; Trophilme D; Le Charpentier M; Dutrillaux B;Klijanienko J; Vielh P: Fine-needle sampling of a case of carcinoma of the breast with neuroendocrine differentiation. Diagn Cytopathol. 1996 May. 14(3). 233-7.
14.- Feczko JD; Rosales RN; Cramer HM; Goulet RJ Jr; Tao LC: Fine needle aspiration cytology of a male breast carcinoma exhibiting neuroendocrine differentiation. Report of a case with immunohistochemical, flow cytometric and ultrastructural analysis. Acta Cytol. 1995 Jul-Aug. 39(4). 803-8.
15.- Frierson HF:Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of teh breast. Am J Surg Pathol. 1991. 15: 358-367.
16.- Pinder SE; Wencyk PM; Naylor HE; Bell JA; Elston CW; Robertson JF; Blamey RW; Ellis IO: The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations. Cytopathology. 1995 Oct. 6(5). 316-24.
17.- Yamamoto N: The objective comparison of nuclear DNA content with nuclear grade in breast cancer: ( English abstract ) Nippon Geka Gakkai Zasshi. 1995 Apr. 96(4). 236-44.
18.- Chen TL; Luo I; Mikhail N; Raskova J; Raska K Jr. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Cytometry. (English Abstract). 1995 Sep 15. 22(3). 181-9.
19.- Baldetorp B; Bendahl PO; Ferno M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjo B; Hockenstrom T; Lindgren A; Mossberg L; et al: Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry. 1995 Jun 15. 22(2). 115-27.
20.- Bergers E; Montironi R; van Diest PJ; Prete E; Baak JP: Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol. 1996 Jun. 27(6). 553-60.
21.- Kallionemi O; Blanco G; Lanslathi K; Lehtinen M; Koivula T:Improving the prognostic value of DNA flow cyitometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer 1988. 62: 2183-2190.
22.- Sharma S; Mishra M; Kapur M; Verma K; Nath I:The prognostic significance of ploidy analysis in operable breast cancer. Cancer. 1991. 58: 2612-2616.
23.- Gonzalez-Morales ML; Furio V; Romam JM; Aguilar-Olivan MA: Prognostic significance of static cytophotometric DNA analysis in invasive ductal breast cancer. Patologia. 1996. 29: 105-113.
24.- Pierga JY; Leroyer A; Viehl P; Mosseri V; Chevillard S; Magdelenat H: Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer. Breast Cancer Res Treat. 1996. 37(1). 57-64.
25.- Kute TE; Quadri Y; Muss H; Zbieranski N; Cirrincione C; Berry DA; Barcos M; Thor AP; Liu E; Koerner F; et al. Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869. Cytometry. 1995 Dec 15. 22(4). 297-306.
26.- Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR: The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Br J Cancer. 1995 Jan. 71(1). 140-5.
27.- Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M: Kilander D, Olsson H, Ranstam J: Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-Phase By optimal categorisation of cut-off levels. Br J Cancer. 1990. 62: 786-790
28.- Baak JPA; Dop H; Kurver PHJ; Hermans J: The value of morphometry to classical prognosticators in breast cancer. Cancer. 1985. 56: 374-382
29.- Keshgegian AA; Cnaan A: Proliferation markers in brast carcinoma. Mitotic figure count S_phase fraction, proliferating cell nuclear antigen, Ki-67 and Mib-1. Am J Clin Pathol. 1995. 104: 42-49
30.- Gaffney EV 2nd; Venz-Williamson TL; Hutchinson G; Biggs PJ; Nelson KM: Relationship of standardized mitotic indices to other prognostic factors in breast cancer. Arch Pathol Lab Med. 1996 May. 120(5). 437-41
31.- Querzoli P; Ferretti S; Albonico G; Magri E; Scapoli D; Indelli M; Nenci I: Application of quantitative analysis to biologic profile evaluation in breast cancer. Cancer. 1995 Dec 15. 76(12). 2510-7.
32.- Jain V; Landry M; Levine EA: The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Am Surg. 1996 Feb. 62(2). 162-5.
33.- Saez R; Clark G, McGuirre W: Prognostic factors in cancer of the breast bailliere's. Clinical Oncology 1982. 2: 103-115
34.- Weidner N; Semple P; Welch W; Folkman J: Tumor angiogenesis and metastasis: correlations in invasive brast carcinoma. N Engl J Med. 1991. 324: 1-8
35.- Casparini G; Harris AL: Clinical importance of the determination of tumor angiogenesis in brast carcinoma: Much more than a new prognosis tool. J Clin Oncology. 1995. 13:765- 782.
36.- Fernández-Aceñero MJ; Fariña J: Valor pronóstico de c-erbB-2, p-53 y neovascularización en el cáncer de mama. Tesis Doctoral del primer autor. Universidad Complutense. 1996.
37.- Santisteban MS; Brugal G: Fluorescence image analysis of the MCF-7 cycle related changes in chromatin texture. differences between AT- and GC-rich chromatin. Anal Cell Pathol. 1995 Jul. 9(1). 13-28.
38.- Haroske G; Friedrich K; Theissig F; Meyer W; Kunze KD. Heterogeneity of the chromatin fine structure in DNA-diploid breast cancer cells. Anal Cell Pathol. 1995 Apr. 8(3). 213-26.
39.- Biesterfeld S; Ruoss E; Hufnagl P; Martin H. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens. Zentralbl Pathol. 1994 Mar. 140(1). 41-8.
40.- Nakayama K; Abe R: Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer. J Surg Oncol. 1995 Nov. 60(3). 160-7.
41.- Ozaki D; Kondo Y: Comparative morphometric studies of benign and malignant intraductal proliferative lesions of the breast by computerized image analysis. Hum Pathol. 1995 Oct. 26(10). 1109-13.
42.- Li X; Melamed MR; Darzynkiewicz Z: Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp Cell Res. 1996. 1: 28-37
43.- Gilles F; Gentile A; Le Doussal V; Bertrand F; Kahn E. Grading of cystosarcoma phyllodes by texture analysis of tissue architecture. Anal Quant Cytol Histol. 1994 Apr. 16(2). 95-100.
44.- Fdez Aceñero MJ, Fariña J, Aragoncillo P. Immunohistochemical expression of p53 and c-erb-b2 in breast carcinoma. Gen and Diagn Pathol (en prensa).
TUMORES DEL OVARIO
1.- Volm M; Kleine W: Prognostische Bedeutung von durchflusszytophotometrischen Untersuchungen beim Ovarialkarzinom. Geburtshilfe Frauenheilkd. 1987 Jul. 47(7). 456-9.
2.- Murray K; Hopwood L; Volk D; Wilson JF: Cytofluorometric analysis of the DNA content in ovarian carcinoma and its relationship to patient survival. Cancer. 1989 Jun 15. 63(12). 2456-60.
3.- Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM: The role of DNA flow cytometry in borderline malignant ovarian tumors. Cancer. 1996 Aug 15. 78(4). 794-802.
4.- Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P: Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary. Int J Gynecol Pathol. 1993 Oct. 12(4). 307-14.NO:91
5.- Isola J; Kallioniemi OP; Korte JM; Wahlstrom T; Aine R; Helle M; Helin H: Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol. 1990 Dec. 162(4). 295-301.
6.- Rotmensch J; Atcher RW; Schwartz JL; Grdina DJ: Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry. Gynecol Oncol. 1992. 44(1): 10-2.
8.- Kuhn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H: Klinischer Verlauf des Ovarialkarzinoms in Abhangigkeit von morphologischen Prognosefaktoren und zellkinetischen parametern. Geburtshilfe Frauenheilkd. (english abstract).1987 Jul. 47(7). 446-51.
9.- Prat J; Matias-Guiu X; Barreto J: Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer. 1991 Dec 1. 68(11). 2455-9.
10.- Kuhn W; Feichter GE; Beier K; Rummel HH; Abel U; Kaufmann M: Zur Dignitat von Psammomkarzinomen des Ovars--eine klinische, DNA-durchflusszytophotometrische und morphometrisch-bildanalytische Studie: Geburtshilfe Frauenheilkd. 1990 Aug. 50(8). 597-604.
11.- Roth LM; Gersell DJ; Ulbright TM; Ovarian Brenner Tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol. 1993. 12(2): 128_33
12.- Trebeck CE; Friedlander ML; Russell P; Baird PJ: Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours. Pathology. 1987 Jul. 19(3). 241-6.
13.- Guerrieri C; Jarlsfelt I: Ependymoma of the ovary. A case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations. Am J Surg Pathol. 1993 Jun. 17(6). 623-32.
14.- Roush GR; el-Naggar AK; Abdul-Karim FW: Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric. Gynecol Oncol. 1995 Mar. 56(3). 430-4.NO:43
15.- Klemi PJ; Joensuu H; Salmi T: Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer. 1990 Mar 1. 65(5). 1189-93.
16.- Buono JP; Dechelotte P; Glowaczower E; Darcha C; Chassagne J; Canis M; Mage G: Analyse de la ploidie dans un cas de carcinome de l'ovaire a petites cellules avec hypercalcemie. Ann Pathol. 1995. 15(2). 134-7.
17.- Young RH; Oliva E; Scully RE: Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases.SO:Am J Surg Pathol. 1994 Nov. 18(11). 1102-16
18.- Silver SA; Wiley JM; Perlman EJ: DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol. 1994 Dec. 7(9). 951-6.NO:62
19.- Oud PS; Soeters RP; Pahlplatz MM; Hermkens HG; Beck HL; Vooijs GP: DNA cytometry of pure dysgerminomas of the ovary. Int J Gynecol Pathol. 1988. 7(3). 258-67.TUMORES DEL
TUMORES DEL UTERO
1.- Gabriele M; Barriere P; Sagot P; Robillard N; Samake M; Lopes P:Interet de l'analyse du cycle cellulaire par cytometrie en flux en gynecologie-obstetrique. J Gynecol Obstet Biol Reprod (Paris). 1989. 18(4). P 463-9.
2.- van Dam PA; Lowe DG; Watson JV; James M; Chard T; Hudson CN; Shepherd JH: Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol Oncol. 1991 Sep. 42(3). P 256-64.
3.- Bocking A: NA-Zytometrie und Automation in der klinischen Diagnostik. Verh Dtsch Ges Pathol. 1990. 74P 176-85.
4.- Rodriguez J; Vicente V; Ochotorena MM; Canteras M: Nucleomorfometría en lesiones por papilomavirus humano (Condilomas y CIN). Patología 1995. 28 (3): 229-2345c.- NO:30
5.- Schlenger K; Hockel M; Mitze M; Schaffer U; Weikel W; Knapstein PG; Lambert A: Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol. 1995 Oct. 59(1). P 57-66.
